FILE - This July 1, 2013, file photo, shows the exterior of the Mallinckrodt Pharmaceuticals office in St. Louis. Mallinckrodt is seeking protection in federal bankruptcy court, as the generic drugmaker deals with lawsuits over its role in the U.S. opioid crisis. The company said Monday, Oct. 12, 2020, that it voluntarily started Chapter 11 proceedings to reduce debt and resolve several billion dollars of possible legal liabilities. (Whitney Curtis/AP Images for Mallinckrodt, File)
Featured Photo Galleries
